This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fernandez, L. A. Articles by Kaczmar, T. Search for Related Content PubMed PubMed Citation Articles by Fernandez, L. A. Articles by Kaczmar, T., Jr

Stroke, Vol 17, 82-85, Copyright © 1986 by American Heart Association

ARTICLES

Angiotensin II decreases mortality rate in gerbils with unilateral carotid ligation

LA Fernandez, DD Spencer and T Kaczmar Jr

Evidence indicates that after vascular occlusion, infusion of angiotensin II restores blood supply to ischemic tissues by stimulating the development of collateral circulation through a mechanism independent of the mechanical effects of increased blood pressure. To test this effect in focal cerebral ischemia, angiotensin II was intravenously administered for four hours to gerbils immediately after unilateral carotid ligation. Three different pressor doses, 50, 250, and 500 ng/kg/min, were used, and mortality rate was evaluated at 1 and 2 days after vascular occlusion. Two additional groups similarly prepared were infused either with saline or with the pressor agent metaraminol. There was a significant inverse relationship between the infusion dose of angiotensin II and mortality: the greater the infusion dose of angiotensin II, the lower the mortality rate. Infusion of metaraminol, at the dose chosen to mimic the pressor effect of the highest angiotensin II dose, yielded a mortality rate which was statistically indistinguishable from that obtained with saline infusion. It is concluded that the mortality rate after unilateral carotid occlusion is significantly reduced by intravenous administration of angiotensin II through mechanisms unrelated to its hypertensive action. Evidence suggests that this may occur by the enhancement of the development of collateral circulation and therefore the reduction of the severity of brain ischemia.

This article has been cited by other articles:

				N. Chitravas, H. M. Dewey, M. B. Nicol, D. L. Harding, D. C. Pearce, and A. G. Thrift Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome? Neurology, May 15, 2007; 68(20): 1687 - 1693. [Abstract] [Full Text] [PDF]

				J. P. Forder, D. H. Munzenmaier, and A. S. Greene Angiogenic protection from focal ischemia with angiotensin II type 1 receptor blockade in the rat Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1989 - H1996. [Abstract] [Full Text] [PDF]

				A. Fournier, F. H. Messerli, J. M. Achard, and L. Fernandez Cerebroprotection mediated by angiotensin II: A hypothesis supported by recent randomized clinical trials J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1343 - 1347. [Abstract] [Full Text] [PDF]

				F. H. Messerli, E. Grossman, and A. F. Lever Do Thiazide Diuretics Confer Specific Protection Against Strokes? Arch Intern Med, November 24, 2003; 163(21): 2557 - 2560. [Abstract] [Full Text] [PDF]

				T. WALTHER, L. OLAH, C. HARMS, B. MAUL, M. BADER, H. HORTNAGL, H.-P. SCHULTHEISS, and G. MIES Ischemic injury in experimental stroke depends on angiotensin II FASEB J, February 1, 2002; 16(2): 169 - 176. [Abstract] [Full Text] [PDF]

				F. Dalmay, H. Mazouz, J. Allard, F. Pesteil, J. M. Achard, and A. Fournier Non-AT1-receptor-mediated protective effect of angiotensin against acute ischaemic stroke in the gerbil Journal of Renin-Angiotensin-Aldosterone System, June 1, 2001; 2(2): 103 - 106. [Abstract] [PDF]

				A. Fournier, A. Pruna, N. E. Esper, R. Makdassi, R. Oprisiu, P.-F. Westeel, H. Mazouz, and J.-M. Achard Captopril prevention project--what shall we do about captopril and the risk of stroke? Nephrol. Dial. Transplant., January 1, 2000; 15(1): 2 - 5. [Full Text] [PDF]